BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8961799)

  • 1. Pharmacokinetics of 99mTc-labeled oligonucleotides.
    Hnatowich DJ
    Q J Nucl Med; 1996 Sep; 40(3):202-8. PubMed ID: 8961799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative properties of a technetium-99m-labeled single-stranded natural DNA and a phosphorothioate derivative in vitro and in mice.
    Hnatowich DJ; Mardirossian G; Fogarasi M; Sano T; Smith CL; Cantor CR; Rusckowski M; Winnard P
    J Pharmacol Exp Ther; 1996 Jan; 276(1):326-34. PubMed ID: 8558450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium-99m labeling of DNA oligonucleotides.
    Hnatowich DJ; Winnard P; Virzi F; Fogarasi M; Sano T; Smith CL; Cantor CR; Rusckowski M
    J Nucl Med; 1995 Dec; 36(12):2306-14. PubMed ID: 8523124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo hybridization of technetium-99m-labeled peptide nucleic acid (PNA).
    Mardirossian G; Lei K; Rusckowski M; Chang F; Qu T; Egholm M; Hnatowich DJ
    J Nucl Med; 1997 Jun; 38(6):907-13. PubMed ID: 9189140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic properties of several novel oligonucleotide analogs in mice.
    Crooke ST; Graham MJ; Zuckerman JE; Brooks D; Conklin BS; Cummins LL; Greig MJ; Guinosso CJ; Kornbrust D; Manoharan M; Sasmor HM; Schleich T; Tivel KL; Griffey RH
    J Pharmacol Exp Ther; 1996 May; 277(2):923-37. PubMed ID: 8627575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The radiolabeling property of oligonucleotide with 99mTc using NHS-MAG3 as a chelator].
    Zhang C; Tan TZ; Kuang AR; Li YC; Zheng JG; Pan WM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):169-71. PubMed ID: 15071906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparison on radiochemical behavior and biological property of antisense oligonucleotide labeled with technetium-99m by two methods: NHS-MAG3 versus SHNHP].
    Li Y; Tan T; Zheng J; Zhang C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):889-93, 902. PubMed ID: 18788302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of chain length and base sequence on the pharmacokinetic behavior of 99mTc-morpholinos in mice.
    Liu G; Zhang S; He J; Liu N; Gupta S; Rusckowski M; Hnatowich DJ
    Q J Nucl Med; 2002 Sep; 46(3):233-43. PubMed ID: 12134139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. II. 3',5'-blocked oligonucleotides.
    Sands H; Gorey-Feret LJ; Ho SP; Bao Y; Cocuzza AJ; Chidester D; Hobbs FW
    Mol Pharmacol; 1995 Mar; 47(3):636-46. PubMed ID: 7700261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic considerations in the development of oligomers as radiopharmaceuticals.
    Hnatowich DJ
    Q J Nucl Med; 1997 Jun; 41(2):91-100. PubMed ID: 9203848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate.
    Sands H; Gorey-Feret LJ; Cocuzza AJ; Hobbs FW; Chidester D; Trainor GL
    Mol Pharmacol; 1994 May; 45(5):932-43. PubMed ID: 8190109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic properties of 2'-O-(2-methoxyethyl)-modified oligonucleotide analogs in rats.
    Geary RS; Watanabe TA; Truong L; Freier S; Lesnik EA; Sioufi NB; Sasmor H; Manoharan M; Levin AA
    J Pharmacol Exp Ther; 2001 Mar; 296(3):890-7. PubMed ID: 11181921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial investigations of 99mTc-labeled morpholinos for radiopharmaceutical applications.
    Mang'era KO; Liu G; Yi W; Zhang Y; Liu N; Gupta S; Rusckowski M; Hnatowich DJ
    Eur J Nucl Med; 2001 Nov; 28(11):1682-9. PubMed ID: 11702111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution of 68Ga-labelled phosphodiester, phosphorothioate, and 2'-O-methyl phosphodiester oligonucleotides in normal rats.
    Lendvai G; Velikyan I; Bergström M; Estrada S; Laryea D; Välilä M; Salomäki S; Långström B; Roivainen A
    Eur J Pharm Sci; 2005 Sep; 26(1):26-38. PubMed ID: 15941654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of hybridization of mRNA of c-myc oncogene with 111In-labeled antisense oligodeoxynucleotide probes by high-pressure liquid chromatography.
    Dewanjee MK; Ghafouripour AK; Kapadvanjwala M; Samy AT
    Biotechniques; 1994 May; 16(5):844-6, 848, 850. PubMed ID: 8068339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular distribution of phosphorothioate oligodeoxynucleotides in normal rodent tissues.
    Butler M; Stecker K; Bennett CF
    Lab Invest; 1997 Oct; 77(4):379-88. PubMed ID: 9354772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular metabolic fate of radioactivity after injection of technetium-99m-labeled hydrazino nicotinamide derivatized proteins.
    Ono M; Arano Y; Uehara T; Fujioka Y; Ogawa K; Namba S; Mukai T; Nakayama M; Saji H
    Bioconjug Chem; 1999; 10(3):386-94. PubMed ID: 10346868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Distribution of oligonucleotide derivatives and their stability in murine tissues].
    Karamyshev VN; Vlasov VV; Zon D; Ivanova EM; Iakubov LA
    Biokhimiia; 1993 Apr; 58(4):590-8. PubMed ID: 8507735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte targeting of 111In-labeled oligo-DNA with avidin or avidin-dendrimer complex.
    Mamede M; Saga T; Ishimori T; Higashi T; Sato N; Kobayashi H; Brechbiel MW; Konishi J
    J Control Release; 2004 Feb; 95(1):133-41. PubMed ID: 15013240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybridisation of [76Br]-labelled antisense oligonucleotides to Chromogranin A mRNA verified by RT-PCR.
    Wu F; Lendvai G; Yngve U; Eriksson B; Långström B; Bergström M
    Nucl Med Biol; 2004 Nov; 31(8):1073-8. PubMed ID: 15607489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.